Long Term Debt Summary of Gilead Sciences, Inc.

Gilead Sciences, Inc.'s latest annual long term debt in 2023 was 23.18 Billion USD , up 1.01% from previous year.
Gilead Sciences, Inc.'s latest quarterly long term debt in 2024 Q1 was 21.52 Billion USD , down -7.17% from previous quarter.
Gilead Sciences, Inc. reported annual long term debt of 22.95 Billion USD in 2022, down -8.82% from previous year.
Gilead Sciences, Inc. reported annual long term debt of 25.17 Billion USD in 2021, down -12.1% from previous year.
Gilead Sciences, Inc. reported quarterly long term debt of 21.54 Billion USD for 2024 Q2, up 0.06% from previous quarter.
Gilead Sciences, Inc. reported quarterly long term debt of 23.18 Billion USD for 2023 FY, up 1.01% from previous quarter.

Annual Long Term Debt Chart of Gilead Sciences, Inc. (2023 - 1990)

Historical Annual Long Term Debt of Gilead Sciences, Inc. (2023 - 1990)

Year	Long Term Debt	Long Term Debt Growth
2023	23.18 Billion USD	1.01%
2022	22.95 Billion USD	-8.82%
2021	25.17 Billion USD	-12.1%
2020	28.64 Billion USD	29.65%
2019	22.09 Billion USD	-10.09%
2018	24.57 Billion USD	-20.2%
2017	30.79 Billion USD	16.89%
2016	26.34 Billion USD	24.3%
2015	21.19 Billion USD	77.8%
2014	11.92 Billion USD	202.66%
2013	3.93 Billion USD	-44.17%
2012	7.05 Billion USD	-7.25%
2011	7.6 Billion USD	158.21%
2010	2.94 Billion USD	137.01%
2009	1.24 Billion USD	-8.38%
2008	1.35 Billion USD	3.42%
2007	1.31 Billion USD	-5.77%
2006	1.39 Billion USD	478.37%
2005	240.65 Million USD	102741.88%
2004	234 Thousand USD	-99.93%
2003	345.32 Million USD	-41.99%
2002	595.27 Million USD	137.74%
2001	250.38 Million USD	-0.73%
2000	252.23 Million USD	197.45%
1999	84.8 Million USD	14033.33%
1998	600 Thousand USD	-53.85%
1997	1.3 Million USD	-55.17%
1996	2.9 Million USD	-17.14%
1995	3.5 Million USD	40.0%
1994	2.5 Million USD	0.0%
1992	1.2 Million USD	71.43%
1991	700 Thousand USD	40.0%
1990	500 Thousand USD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	21.52 Billion USD	-7.17%
2024 Q2	21.54 Billion USD	0.06%
2023 FY	23.18 Billion USD	1.01%
2023 Q1	24.23 Billion USD	5.56%
2023 Q3	24.11 Billion USD	6.87%
2023 Q2	22.56 Billion USD	-6.89%
2023 Q4	23.18 Billion USD	-3.83%
2022 Q1	25.18 Billion USD	0.02%
2022 Q3	22.95 Billion USD	-8.9%
2022 FY	22.95 Billion USD	-8.82%
2022 Q2	25.19 Billion USD	0.05%
2022 Q4	22.95 Billion USD	0.02%
2021 Q1	27.9 Billion USD	-2.58%
2021 Q2	27.91 Billion USD	0.03%
2021 Q3	25.17 Billion USD	-9.81%
2021 Q4	25.17 Billion USD	0.02%
2021 FY	25.17 Billion USD	-12.1%
2020 Q3	27.79 Billion USD	31.7%
2020 Q2	21.1 Billion USD	-4.5%
2020 FY	28.64 Billion USD	29.65%
2020 Q1	22.09 Billion USD	0.02%
2020 Q4	28.64 Billion USD	3.07%
2019 Q1	24.08 Billion USD	-2.01%
2019 Q3	22.09 Billion USD	-8.28%
2019 Q2	24.08 Billion USD	0.02%
2019 FY	22.09 Billion USD	-10.09%
2019 Q4	22.09 Billion USD	0.02%
2018 Q3	24.57 Billion USD	-5.72%
2018 Q2	26.06 Billion USD	-1.86%
2018 Q4	24.57 Billion USD	0.02%
2018 Q1	26.55 Billion USD	-13.76%
2018 FY	24.57 Billion USD	-20.2%
2017 FY	30.79 Billion USD	16.89%
2017 Q4	30.79 Billion USD	11.92%
2017 Q3	27.51 Billion USD	4.64%
2017 Q2	26.29 Billion USD	-0.09%
2017 Q1	26.32 Billion USD	-0.09%
2016 Q3	26.37 Billion USD	23.07%
2016 Q1	21.07 Billion USD	-0.56%
2016 Q2	21.42 Billion USD	1.66%
2016 Q4	26.34 Billion USD	-0.09%
2016 FY	26.34 Billion USD	24.3%
2015 Q2	11.92 Billion USD	0.01%
2015 Q4	21.19 Billion USD	-3.19%
2015 FY	21.19 Billion USD	77.8%
2015 Q3	21.89 Billion USD	83.64%
2015 Q1	11.92 Billion USD	0.0%
2014 Q4	11.92 Billion USD	50.27%
2014 Q3	7.93 Billion USD	0.01%
2014 Q2	7.93 Billion USD	0.01%
2014 FY	11.92 Billion USD	202.66%
2014 Q1	7.93 Billion USD	101.39%
2013 Q4	3.93 Billion USD	-32.74%
2013 Q3	5.85 Billion USD	0.11%
2013 FY	3.93 Billion USD	-44.17%
2013 Q1	7.05 Billion USD	0.0%
2013 Q2	5.84 Billion USD	-17.08%
2012 Q2	7.12 Billion USD	-11.77%
2012 FY	7.05 Billion USD	-7.25%
2012 Q4	7.05 Billion USD	0.2%
2012 Q3	7.04 Billion USD	-1.21%
2012 Q1	8.07 Billion USD	6.2%
2011 FY	7.6 Billion USD	158.21%
2011 Q4	7.6 Billion USD	95.43%
2011 Q3	3.89 Billion USD	0.54%
2011 Q2	3.87 Billion USD	0.54%
2011 Q1	3.85 Billion USD	30.71%
2010 Q4	2.94 Billion USD	4.5%
2010 Q1	1.23 Billion USD	-0.48%
2010 FY	2.94 Billion USD	137.01%
2010 Q2	628.4 Million USD	-49.19%
2010 Q3	2.81 Billion USD	348.55%
2009 Q3	1.2 Billion USD	1.42%
2009 Q1	1.16 Billion USD	-13.86%
2009 Q4	1.24 Billion USD	2.83%
2009 FY	1.24 Billion USD	-8.38%
2009 Q2	1.19 Billion USD	1.99%
2008 Q2	26.45 Million USD	-97.98%
2008 Q1	1.31 Billion USD	-0.1%
2008 Q4	1.35 Billion USD	2.67%
2008 Q3	1.32 Billion USD	4894.6%
2008 FY	1.35 Billion USD	3.42%
2007 FY	1.31 Billion USD	-5.77%
2007 Q3	1.41 Billion USD	0.84%
2007 Q1	1.39 Billion USD	0.3%
2007 Q2	1.4 Billion USD	0.81%
2007 Q4	1.31 Billion USD	-7.57%
2006 Q3	1.38 Billion USD	-4.1%
2006 Q2	1.43 Billion USD	680.67%
2006 Q4	1.39 Billion USD	0.83%
2006 Q1	184.38 Million USD	-23.38%
2006 FY	1.39 Billion USD	478.37%
2005 FY	240.65 Million USD	102741.88%
2005 Q4	240.65 Million USD	82597.59%
2005 Q3	291 Thousand USD	-0.68%
2005 Q2	293 Thousand USD	13.13%
2005 Q1	259 Thousand USD	10.68%
2004 Q3	345.29 Million USD	-0.0%
2004 Q2	345.3 Million USD	-0.01%
2004 Q1	345.33 Million USD	0.0%
2004 FY	234 Thousand USD	-99.93%
2004 Q4	234 Thousand USD	-99.93%
2003 FY	345.32 Million USD	-41.99%
2003 Q4	345.32 Million USD	-42.0%
2003 Q3	595.39 Million USD	0.01%
2003 Q2	595.32 Million USD	0.06%
2003 Q1	595 Million USD	-0.05%
2002 Q1	250.33 Million USD	-0.02%
2002 Q4	595.27 Million USD	138.11%
2002 Q3	250 Million USD	-0.12%
2002 Q2	250.29 Million USD	-0.01%
2002 FY	595.27 Million USD	137.74%
2001 Q3	250.75 Million USD	-0.26%
2001 Q1	251.94 Million USD	-0.12%
2001 FY	250.38 Million USD	-0.73%
2001 Q4	250.38 Million USD	-0.14%
2001 Q2	251.41 Million USD	-0.21%
2000 Q4	252.23 Million USD	7948.44%
2000 Q2	83.37 Million USD	-0.76%
2000 Q1	84.01 Million USD	-0.92%
2000 FY	252.23 Million USD	197.45%
2000 Q3	3.13 Million USD	-96.24%
1999 Q3	92.6 Million USD	46200.0%
1999 Q2	200 Thousand USD	-50.0%
1999 Q4	84.8 Million USD	-8.42%
1999 Q1	400 Thousand USD	-33.33%
1999 FY	84.8 Million USD	14033.33%
1998 Q3	700 Thousand USD	-22.22%
1998 Q2	900 Thousand USD	-18.18%
1998 FY	600 Thousand USD	-53.85%
1998 Q4	600 Thousand USD	-14.29%
1998 Q1	1.1 Million USD	-15.38%
1997 Q2	1.8 Million USD	-18.18%
1997 Q1	2.2 Million USD	-24.14%
1997 FY	1.3 Million USD	-55.17%
1997 Q3	1.6 Million USD	-11.11%
1997 Q4	1.3 Million USD	-18.75%
1996 Q3	1.5 Million USD	-28.57%
1996 Q4	2.9 Million USD	93.33%
1996 Q2	2.1 Million USD	-25.0%
1996 Q1	2.8 Million USD	0.0%
1996 FY	2.9 Million USD	-17.14%
1995 Q3	4.1 Million USD	-14.58%
1995 Q1	5.4 Million USD	-12.9%
1995 Q2	4.8 Million USD	-11.11%
1995 FY	3.5 Million USD	40.0%
1994 Q1	2.5 Million USD	-3.85%
1994 FY	2.5 Million USD	0.0%
1994 Q4	6.2 Million USD	-4.62%
1994 Q3	6.5 Million USD	-4.41%
1994 Q2	6.8 Million USD	172.0%
1993 Q1	1.2 Million USD	9.09%
1993 Q2	1.4 Million USD	16.67%
1993 Q3	2 Million USD	42.86%
1993 Q4	2.6 Million USD	30.0%
1992 Q1	700 Thousand USD	0.0%
1992 Q3	1 Million USD	42.86%
1992 FY	1.2 Million USD	71.43%
1992 Q4	1.1 Million USD	10.0%
1992 Q2	700 Thousand USD	0.0%
1991 Q1	500 Thousand USD	0.0%
1991 FY	700 Thousand USD	40.0%
1990 FY	500 Thousand USD	0.0%

Peer Long Term Debt Comparison of Gilead Sciences, Inc.

Name	Long Term Debt	Long Term Debt Difference
Amgen Inc.	63.17 Billion USD	63.291%
AstraZeneca PLC	23.22 Billion USD	0.142%
Biogen Inc.	7.18 Billion USD	-222.598%
MIRA Pharmaceuticals, Inc.	- USD	-Infinity%
Scilex Holding Company	17.03 Million USD	-136001.655%
Scilex Holding Company	17.03 Million USD	-136001.655%

Global Stocks Search

Gilead Sciences, Inc. (GILD)

Long Term Debt Summary of Gilead Sciences, Inc.

Annual Long Term Debt Chart of Gilead Sciences, Inc. (2023 - 1990)

Historical Annual Long Term Debt of Gilead Sciences, Inc. (2023 - 1990)

Peer Long Term Debt Comparison of Gilead Sciences, Inc.